Tirzepatide is an injectable diabetic medication. It is given weekly. This medicine treats two issues simultaneously, unlike others.
The target audience is type 2 diabetics, but weight loss is achievable off-label. Tirzepatide works well with a healthy diet and exercise.
Tirzepatide works by activating GLP-1 and GIP receptors. Controlling appetite and blood sugar requires these receptors. After eating, the body releases GLP-1 and GIP. They lower blood sugar by signaling the brain to lessen appetite and increase fullness.
As an agonist, it activates GLP-1 and GIP receptors greater than hormones. Tirzepatide promotes insulin secretion, reduces blood sugar, and increases satiety to help lose weight.
All patients should start on a low dose of Tirzepatide, at 2.5 mg, to see how their bodies react to it. Always take your doctor's recommendations seriously. Here is the suggested Tirzepatide dosing schedule: